Hypertension in the elderly and the very old

References

• Casiglia E, Spolaore P, Mormino P et al. The CASTEL project (Cardiovascular Study in the Elderly): protocol, study design, and preliminary results of the initial survey. Cardiologia36, 569–576 (1991).
   PubMedGoogle Scholar
• Casiglia E, Palatini P. Cardiovascular risk factors in the elderly. J. Hum. Hypertens.12, 575–581 (1998).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Mazza A, Tikhonoff V et al. Protocol and experimental design of the LEOGRA (Last Evidences Of Genetic Risk factors in the Aged) study, a population-based genetic approach to cardiovasclar risk. J. Hypertens.18(Suppl. 2), 174 (2000).
   Google Scholar
• Casiglia E, Basso G, Guglielmi F et al. German origin clusters for high cardiovascular risk in an italian enclave. Int. Heart. J.46, 489–500 (2005).
   PubMed Web of Science ®Google Scholar
• Ambrosio GB, Zamboni S, Gabaldo S et al. Screening of hypertension in a community. Data from the Camposampiero Project. G. Ital. Cardiol.8, 1161–1167 (1978).
   PubMedGoogle Scholar
• Ambrosio GB, Zamboni S, Vanuzzo D et al. Prevalene of arterial hypertension in the community. Experience of the province of Veneto. G. Ital. Cardiol.10, 1280–1287 (1980).
   PubMedGoogle Scholar
• Ginocchio G, Staessen JA, Casiglia E, D’Este D, Fagard R, Pessina AC. Life-style and blood pressure. The Mirano study. J. Hypertens.15(Suppl. 4), 106 (1997).
   Google Scholar
• Casiglia E, D’Este D, Ginocchio G et al. Lack of influence of menopause on blood pressure and cardiovascular risk profile. J. Hypertens.14, 729–736 (1996).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Ginocchio G, Tikhonoff V et al. Blood pressure and metabolic profile after surgical menopause. Comparison with fertile and naturally-menopausal women. J. Hum. Hypertens.14, 799–806 (2000).
   PubMed Web of Science ®Google Scholar
• Kuznetsova T, Staessen JA, Kawecka-Jaszcs K et al. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press. Monit.7, 251–224 (2002).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Tikhonoff V, Mazza A, Pessina AC. Systolic and pulse hypertension. Aging Health1, 85–94 (2005).
   Google Scholar
• Williams B, Lindholm LH, Sever P. Systolic pressure is all that matters. Lancet371, 2219–2220 (2008).
   PubMed Web of Science ®Google Scholar
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA289, 2560–2572 (2003).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Mazza A, Tikhonoff V et al. Arterial hypertension and mortality in the elderly. Am. J. Hypertens.15, 958–966 (2002).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Spolaore P, Ginocchio G et al. Mortality in very old subjects aged 80 years or over. The CASTEL (Cardiovascular Study in the Elderly). Eur. J. Epidemiol.9, 577–586 (1993).
   PubMed Web of Science ®Google Scholar
• Meeks WM. Pathophysiology of hypertension in the elderly. Sem. Nephrol.22, 65–70, (2002).
   PubMed Web of Science ®Google Scholar
• Elliott RJ, McGrath LT. Calcification of the human thoracic aorta during age. Calcif. Tissue. Int.54, 268–273 (1994).
   PubMed Web of Science ®Google Scholar
• Dart AM, Kingwell BA. Pulse pressure – a review of mechanisms and clinical relevance. JACC37, 975–984 (2001).
   Google Scholar
• Nichols WW, O’Rouke MF, Avolio AP et al. Effects of age on ventricular-vascular coupling. Am. J. Cardiol.15, 1179–1184 (1985).
   Google Scholar
• Smulyan H, Safar M. Systolic blood pressure revisited. JACC29, 1047–1113 (1997).
   Google Scholar
• Safar ME, Laurent P. Pulse pressure and arterial stiffness in rats. Comparison with humans. Am. J. Physiol. Heart Circ. Physiol.285, 1363H–1369H (2003).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Mazza A, Tikhonoff V et al. Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll. J. Human. Hypert.16, 21–31 (2002).
   PubMed Web of Science ®Google Scholar
• Pavan L, Casiglia E, Pauletto P et al. Blood pressure, serum cholesterol and nutritional state in Tanzania and in Amazons. Comparison with an italian population. J. Hypertens.15, 1083–1090 (1997).
   PubMed Web of Science ®Google Scholar
• Pavan L, Casiglia E, Carvalho Braga LM et al. Effects of a traditional lifestyle on the cardiovascular risk profile. The Amondava population of the Brazilian Amazon. Comparison with matched African, Italian and Polish populations. J. Hypertens.17, 749–756 (1999).
   PubMed Web of Science ®Google Scholar
• Pauletto P, Puato M, Caroli MG et al. Blood pressure and atherogenic lipoprotein profiles of fish-diet and vegetarian villagers in Tanzania. The Lugalawa study. Lancet348, 784–788 (1996).
   PubMed Web of Science ®Google Scholar
• Palatini P, Palomba D, Bertolo O et al. The white-coat effect is unrelated to the difference between clinic and daytime blood pressure and is associated with greater reactivity to public speaking. J. Hypertens.21, 545–553 (2003).
   PubMed Web of Science ®Google Scholar
• Timio M, Lippi G, Venanzi S et al. Blood pressure trend and cardiovascular events in nuns in a secluded order. A 30-year follow-up study. Blood Press.6, 81–87 (1997).
   PubMedGoogle Scholar
• Davies E, Holloway CD, Ingram MC et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension33, 703–707 (1999).
   PubMed Web of Science ®Google Scholar
• Barbato A, Russo P, Siani A et al. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J. Hypertens.22, 1895–1901 (2004).
   PubMed Web of Science ®Google Scholar
• Matsubara M, Sato T, Nishimura T et al. CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese. The Ohasama study. Hypertens. Res.27, 1–6 (2004).
   PubMed Web of Science ®Google Scholar
• Zhu H, Sagnella GA, Dong Y et al. Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J. Hypertens.21, 87–95 (2003).
   PubMed Web of Science ®Google Scholar
• Staessen J, Wang JG, Brand E et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J. Hypertens.19, 1349–1358 (2001).
   PubMed Web of Science ®Google Scholar
• Tikhonoff V, Kuznetsova T, Stolarz K et al. Modulation of genetic cardiovascular risk by age and lifestyle. Curr. Cardiovasc. Risk Rep.2(5), 398–404 (2008).
   Google Scholar
• Casiglia E, Tikhonoff V, Mazza A et al. C-344T polymorphis of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J. Hypertens.23, 1991–1996 (2005).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Tikhonoff V, Schiavon L et al. Skinfold thickness and blood pressure across C-344T polymorphism of CYP11B2 gene. J. Hypertens.25, 1828–1833 (2007).
   PubMed Web of Science ®Google Scholar
• Kuznetsova T, Staessen JA, Brand E et al. Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the european project on genes in hypertension. J. Hypertens.24, 235–242 (2006).
   PubMed Web of Science ®Google Scholar
• Tikhonoff V, Kuznetsova T, Stolarz K et al. B-adducin polymorphism, blood pressure, and sodium excretion in three European populations. Am. J. Hypertens.16, 840–846 (2003).
   PubMed Web of Science ®Google Scholar
• Stolarz K, Staessen JA, Kawecka-Jaszcz K et al. Genetic variation in CYP11B2 and AT1R influences heart rate variability conditional on sodium excretion. Hypertension44, 156–162 (2004).
   PubMed Web of Science ®Google Scholar
• Kuznetsova T, Staessen JA, Thjis L et al. Left ventricular mass in relation to genetic variation in angiotensin ii receptors, renin system genes, and sodium excretion. Circulation110, 2644–2650 (2004).
   PubMed Web of Science ®Google Scholar
• Kuznetsova T, Staessen JA, Reineke T et al. Context–dependency of the relation between left ventricular mass and AGT gene variants. J. Hum. Hypertens.19, 155–163 (2005).
   PubMed Web of Science ®Google Scholar
• Kuznetsova T, Staessen JA, Stolarz K et al. Relationship between left ventricular mass and the ace d/i polymorphism varies according to sodium intake. J. Hypertens.22, 287–295 (2004).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Tikhonoff V, Mazza A et al. Pulse pressure and coronary mortality in elderly men and women from general population. J. Hum. Hypertens.16, 611–620 (2002).
   PubMed Web of Science ®Google Scholar
• Mazza A, Pessina AC, Privato G, Tikhonoff V, Pavei A, Casiglia E. Pulse pressure: an independent predictor of coronary and stroke mortality in elderly females from the general population. Blood Press.10, 205–211 (2001).
   PubMed Web of Science ®Google Scholar
• Stokes GS. Systolic hypertension in the elderly. Pushing the frontiers of therapy – a suggested new approach. J. Clin. Hypertens.6, 192–197 (2004).
   Google Scholar
• Staessen JA, Gasowski J, Wang JG et al. Risks of untreated and treated isolated systolic hypertension in the elderly. Meta-analysis of outcome trials. Lancet11, 355 865–872 (2000).
   Google Scholar
• Aviv A. Pulse pressure and human longevity. Hypertension37, 1060–1066 (2001).
   PubMed Web of Science ®Google Scholar
• Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation100, 354–360 (1999).
   PubMed Web of Science ®Google Scholar
• Franklin SS. Arterial stiffness and hypertension. A two-way street. Hypertension45, 349–351 (2005).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Tikhonoff V, Mazza A, Pessina AC. Systolic and pulse hypertension. Aging Health1, 85–94 (2005).
   Google Scholar
• Casiglia E, Maniati G, Daskalakis C et al. Left ventricular hypertrophy in the elderly. Unreliability of electrocardiographic criteria in 477 subjects ages 65 years or more. The Cardiovascular Study in the Elderly (CASTEL). Cardiology87, 429–435 (1996).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Daskalakis C, Maniati G et al. Left ventricular hypertrophy is not a predictor of mortality in the elderly. High BP6, 12–21 (1997).
   Google Scholar
• Casiglia E, Spolaore P, Ginocchio G et al. Predictors of mortality in very old subjects aged 80 years or over. Eur. J. Epidemiol.9, 577–586 (1993).
   PubMed Web of Science ®Google Scholar
• Dal Palù C, Casiglia E, Pessina AC. The CASTEL (Cardiovascular Study in the Elderly). Prediction of cariovascular mortality in a general population aged 65 years or over. In: World Hypertension League Yearbook 2000–2001. World Hypertension League, Burnaby, Canada (2001).
   Google Scholar
• Casiglia E, Spolaore P, Ginocchio G et al. Proteinuria predicts mortality among elderly but not among very old subjects. J. Nephrol.5, 89–93 (1993).
   Google Scholar
• Casiglia E, Ginocchio G, Spolaore P et al. Only uric acid and FEV1 are predictors of mortality in very old subjects. Acta Cardiol.48, 290–292 (1993).
   Google Scholar
• Mazza A, Tikhonoff V, Casiglia E, Pessina AC. Body mass index and mortality in the elderly from general population. Gerontology53, 36–45 (2007).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Tikhonoff V. Inflammatory and coagulative markers of atherosclerosis. Eur. Heart J.28, 271–273 (2007).
   PubMed Web of Science ®Google Scholar
• Gueyffier F, Bulpitt C, Boissel JP et al. Antihypertensive drugs and very old people: a subgroup meta-analysis of randomised controlled trials. Lancet353, 793–796 (1999).
   PubMed Web of Science ®Google Scholar
• Pessina AC, Casiglia E. Are hypertensive patients undertreated? Aging Health1, 355–357 (2006).
   Google Scholar
• Casiglia E, Mazza A, Tikhonoff V, Pessina AC. Population-based studies improve outcome in hypertensive patients. Am. J. Hypertens.15, 605–608 (2002).
   PubMed Web of Science ®Google Scholar
• Casiglia E, Saugo M, Schiavon L et al. Reduction of cardiovascular risk and mortality. A population-based study. Adv. Ther.23, 905–920 (2006).
   PubMed Web of Science ®Google Scholar
• Tikhonoff V, Casiglia E, Nawrot T, Staessen JA. Should high-normal blood pressure be treated? J. Hypertens.20, 1–2 (2002).
   Web of Science ®Google Scholar
• Casiglia E, Spolaore P, Mazza A et al. Effects of two different therapeutic approaches on total and cardiovascular mortality in the CArdiovascular STudy in the ELderly (CASTEL). Jap. Heart J.35, 589–600 (1994).
   PubMedGoogle Scholar
• Firdaus M, Sivaram CA, Reynolds DW. Prevention of cardiovascular events by treating hypertension in older adults. An evidence-based approach. J. Clin. Hypertens. (Greenwich) 10, 219–225 (2008).
   PubMed Web of Science ®Google Scholar
• Blacher J, Staessen JA, Girend X et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch. Inter. Med.160, 1085–1089, 2000.
   PubMed Web of Science ®Google Scholar
• Smulyan H, Safar ME. The diastolic blood pressure in systolic hypertension. Ann. Intern. Med.132, 233–237 (2000).
   PubMed Web of Science ®Google Scholar
• Benetos A, Thomas F, Safar ME, Bean KE, Guize L. Should diastiolic and systolic blood pressure be considered for cardiovascular risk evaluation: a study in middle-aged men and women. J. Am. Coll. Cardiol.37, 163–168 (2001).
   PubMed Web of Science ®Google Scholar
• Aronow WS. Treatment of hypertension in the elderly. Geriatrics63, 21–25 (2008).
   PubMed Web of Science ®Google Scholar
• Berlowitz DR, Ash AS, Hockey EC et al. Inadeguate management of high blood pressure in a hypertensive population. N. Engl. J. Med.339, 1957–1963 (1998).
   PubMed Web of Science ®Google Scholar
• Banegas J, Rodrigues-Artalejo F, Ruilope M et al. Hypertension magnitude and management in the elderly population of Spain. J. Hypertens.20, 2157–2164 (2002).
   PubMed Web of Science ®Google Scholar
• Staessen JA, Thjis L, Fagard R et al. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J. Hypertens.22, 847–857 (2004).
   PubMed Web of Science ®Google Scholar
• Michak JL, Carter BL, Ardery G, Dawson JD, Harmston M, Franciscus CL. Physician adherence to blood pressure guidelines and its effect on seniors. Pharmacotherapy28, 843–851 (2008).
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Evans JC, Larson MG, Levy D. Treatment and control of hypertension in the community. A prospective analysis. Hypertension40, 640–646 (2002).
   PubMed Web of Science ®Google Scholar
• Psati BM, Manolio TA, Smith NL et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults. Arch. Intern. Med.162, 2325–2332 (2002).
   PubMedGoogle Scholar
• Alam M, Barri YM. Systolic blood pressure is the main aetiology of poorly controlled hypertension. Am. J. Hypertens.16, 140–143 (2003).
   PubMed Web of Science ®Google Scholar
• Kannel WB. Prevalence and implications of uncontrolled systolic hypertesion. Drugs Aging20, 277–286 (2003).
   PubMed Web of Science ®Google Scholar
• Waeber B, Mourad JJ. Targeting systolic blood pressure: the key to control combined systolic/diastolic hypertension. Am. J. Hypertens.19, 985–986 (2006).
   PubMed Web of Science ®Google Scholar
• Oliveira SA, Lapuerta P, McCarthy BD et al. Physician-retated barriers to the effective management of uncontrolled hypertension. Arch. Intern. Med.162, 413–420 (2002).
   PubMedGoogle Scholar
• Zanchetti A. Target blood pressure in elderly hypertensive patients: how low should you go? Blood Press.2(Suppl.), 7–11 (2000).
   Google Scholar
• Forette F, Seux MI, Staessen JA et al. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe Trial. Lancet352, 1347–1351 (1998).
   PubMed Web of Science ®Google Scholar
• Martin-Schild S, Hallevi H, Albright KC et al. Aggressive blood pressure-lowering treatment before intravenous plasminogen activator therapy in acute ischemic stroke. Arch. Neurol.65, 1174–1178 (2008).
   PubMedGoogle Scholar
• Thjis L, Staessen JA, Beleva S et al. How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe follow-up study. Curr. Control Trials Cardiovasc. Med.2, 298–306 (2001).
   PubMedGoogle Scholar